KOBAYASHI PHARMACEUTICAL Aktie

 

The Osaka-based company has replaced its president twice and appointed an external chairman, seeking to reduce the influence of the founding family seen as a cause of the scandal....

In March 2024, the drugmaker, based in Osaka, announced that it had received a series of reports about such symptoms as kidney disease from users of its supplements....

Osaka, June 4 (Jiji Press)--The head of Kobayashi Pharmaceutical Co. has promised that it will never cause health damage again, following a high-profile scare last year caused by its supplements containing "beni koji," or red fermented rice. "I will continue to urge our workers to never repeat" such health hazards, President and CEO Norikazu Toyoda said in a recent interview held after taki......

Osaka, March 28 (Jiji Press)--Kobayashi Pharmaceutical Co. on Friday promoted executive officer Norikazu Toyoda to its president and CEO after shareholders approved the company's proposed slate of 10 board nominees, including him. Yoshihito Ota, who helped turn around Japan Airlines, became chairman of the scandal-tainted Japanese drugmaker. The changes come as Kobayashi Pharmaceutical, b......

Osaka, March 28 (Jiji Press)--Shareholders of Kobayashi Pharmaceutical Co. on Friday approved the company's proposed slate of 10 board nominees, including executive officer Norikazu Toyoda, who is set to become new president and CEO of the scandal-tainted Japanese company. The 10 also include Yoshihito Ota, who helped turn around Japan Airlines and will become chairman of the drugmaker. T......

From Brain Fog To Allergies: The Health Risks Of Mold and How To Tackle It Au thored by JoJo Novaes and Connie Lai via The Epoch Times (emphasis ours), Mold is more than just an aesthetic problem in a home; it can also pose a threat to your health. Exposure to mold has been linked to conditions, including allergic rhinitis, asthma, and even cognitive issues like brain fog. Yury Nikolaev/Shutterstock In the “Health 1+1” program, Shao-Hung Wang, professor and chair of the Microbiology, Immunology, and Biopharmaceuticals Department at National Chiayi University in Taiwan, discussed the increasing number of mold-related poisoning incidents in recent years. He cited the 2004 contamination of Pedigree dog food, which led to kidney failure in approximately 6,000 dogs in Taiwan alone. More recently, in March of last year, toxic puberulic acid was found in red yeast rice supplements from Japan's Kobayashi Pharmaceutical, a drug-maker company, resulting in over 100 deaths. During the program, Wang ...

Osaka, Feb. 19 (Jiji Press)--Kobayashi Pharmaceutical Co. shareholders voted down proposals by Hong Kong-based investment fund Oasis Management Co. at their extraordinary meeting in Osaka on Wednesday. Oasis, whose stake in the Japanese maker and seller of over-the-counter drugs and supplements tops 10 pct, proposed that lawyer Yoshio Nakamura and two others be appointed as outside board dir......

(Securities Code: 4967 JT) * Oasis nominated independent investigator to lead investigation into recent Beni-Koji scandal *Oasis nominated three highly qualified, independent, diverse director candidates * Proxy advisory firms ISS and Glass Lewis support Oasis's independent director candidates * Proxy advisory firm ISS supports appointment of Oasis's independent investigator candidate * Oasis reiterates its recommendations to Kobayashi Pharma shareholders to vote FOR Oasis's proposals to improve Kobayashi Pharma's governance and to improve its health and safety standards for all stakeholders More information available at www.KobayashiCorpGov.com HONG KONG--(BUSINESS WIRE)--Oasis Management Company Ltd. (“Oasis”) is the manager to funds that beneficially own over 10.1% of Japanese pharmaceuticals and food products manufacturer Kobayashi Pharmaceutical Co., Ltd. (4967 JT) (“Kobayashi Pharma” or the “Company”). As Kobayashi Pharma's second largest shareholder and the largest institutional sh...

The company's net profit plunged 50.5% in the aftermath of a health scandal involving its supplements, which emerged last year....

Osaka, Feb. 10 (Jiji Press)--Kobayashi Pharmaceutical Co. said Monday that it suffered the first year-on-year decline in its group net profit since its stock listing in 1999 in the business year ended in December last year. The company's net profit plunged 50.5 pct to 10,067 million yen in the aftermath of a health hazard scandal involving its supplements containing "beni koji" red fermented......

Tokyo, Jan. 28 (Jiji Press)--Hong Kong-based investment fund Oasis Management Co. said Tuesday that it plans to file a damages lawsuit against the former chairman of Kobayashi Pharmaceutical Co. and others over a high-profile health hazard scandal involving supplements containing "beni koji" red fermented rice. In the shareholder derivative suit, the fund will seek a total of roughly 11 bill......

Osaka, Jan. 21 (Jiji Press)--Scandal-tainted Kobayashi Pharmaceutical Co. said Tuesday that its current president, Satoshi Yamane, will step down and executive officer Norikazu Toyoda will assume the presidency. The personnel plan is expected to be approved at a board meeting following a general shareholders meeting in late March. Yamane took office last August after then President Akihir......

Das Instrument KOY JP3301100008 KOBAYASHI PHARMACEUT. EQUITY wird ex Dividende/Zinsen gehandelt am 27.12.2024 The instrument KOY JP3301100008 KOBAYASHI PHARMACEUT. EQUITY has its ex-dividend/interest day on 27.12.2024...

Oasis Management said its stake in Kobayashi Pharmaceutical climbed to 10.1% from 7.5%....

Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...

Taipei, Sept. 28 (Jiji Press)--A Taiwanese consumer group sued Japan's Kobayashi Pharmaceutical Co. for compensation for health damage allegedly caused by products related to its "beni koji" red fermented rice on Friday, Taiwanese media reported. The group filed the lawsuit with Taipei District Court against six firms including a Taiwanese unit of Kobayashi Pharmaceutical and an importer in......

A group filed the lawsuit with the Taipei District Court against six firms including a Taiwanese unit of Kobayashi Pharmaceutical and an importer in Taiwan....

Tokyo, Sept. 18 (Jiji Press)--Japan's health ministry said Wednesday that puberulic acid caused kidney damage to users of Kobayashi Pharmaceutical Co.'s supplements containing "beni koji" red fermented rice. The acid is one of three chemical compounds detected in the supplements, while no kidney toxicity was confirmed in animal experiments from the other two compounds, the ministry said. ......

Osaka, Aug. 27 (Jiji Press)--The western Japan city of Osaka conducted on Tuesday its third on-site inspection of a former plant of Kobayashi Pharmaceutical Co. over health problems suffered by users of its supplements. The plant in the capital of Osaka Prefecture, closed last December, produced "beni koji" red fermented rice, contained in the company's supplements believed to have caused t......